We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Dalton Pharma and Boehringer Ingelheim Announce the Renewal of Chemistry Services Agreement
News

Dalton Pharma and Boehringer Ingelheim Announce the Renewal of Chemistry Services Agreement

Dalton Pharma and Boehringer Ingelheim Announce the Renewal of Chemistry Services Agreement
News

Dalton Pharma and Boehringer Ingelheim Announce the Renewal of Chemistry Services Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Dalton Pharma and Boehringer Ingelheim Announce the Renewal of Chemistry Services Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd.

Under the agreement Dalton will continue to provide chemistry services in support of Boehringer’s pharmaceutical development programs.

Peter Pekos, President of Dalton Pharma Services, said: “We are extremely pleased to continue our relationship with Boehringer Ingelheim (Canada) Ltd. The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim’s deep commitment to research in Canada. We look forward to another successful collaboration with this world class organization.”
Advertisement